Document is current
Any future updates will be listed below
-
Authors
Foers, Andrew D.
Reekie, Ian R.
Wickramasinghe, Lakshanie C.
Ward, Amy
Buckley, Thomas MW.
Attar, Moustafa
Aguilar-Munoa, Soledad
Pilapil, Queen
Elsayed, Maram EA. Abdalla
Pledger, Sam
Bhalla, Ananya
Hedley, Robert
Hill, Sarah
Windell, Dylan
Barton, Keith
Masood, Imran
Lim, Kin Sheng
Coles, Mark C.
Sherlock, Jonathan P.
Dick, Andrew D.
Coupland, Sarah E.
Sansom, Stephen N.
Copland, David A.
Buckley, Christopher D.
Sharma, Srilakshmi M.
,
Chu, Colin J.
Foers, Andrew D.
Reekie, Ian R.
Wickramasinghe, Lakshanie C.
Ward, Amy
Hedley, Robert
Sherlock, Jonathan P.
Dick, Andrew D.
Coupland, Sarah E.
Copland, David A.
Buckley, Christopher D.
Sharma, Srilakshmi M.
-
Funding
Funding for this research was provided by:
Oxfordshire Health Services Research Committee (1396)
Kennedy Trust for Rheumatology Research (KENN202101)
Johnson & Johnson Innovative Medicine
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology (BRC4-03-RB414-405)
Versus Arthritis (22252)
Arthritis Therapy Acceleration Programme
Medical Research Council (MR/T024682/1)
- License Information
-
More Information
Article History
Received: 2 September 2025
Accepted: 18 December 2025
First Online: 3 April 2026
Declarations
:
: ADF, AW and LW received salary and research support from Janssen Pharmaceuticals. CDP and ADD served as consultants for and/or received honoraria from Janssen. JSP was employed by Janssen and holds stock in Johnson & Johnson. The other authors declare no competing interests.
